Methods For The Treatment Of Scleroderma

Patent No. EP3860590 (titled "Methods For The Treatment Of Scleroderma") was filed by Arena Pharmaceuticals on Oct 3, 2019. The application was issued on Jun 7, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMM & WITTKOPPMar 7, 2024HAMM & WITTKOPP
TEVA PHARMACEUTICALSFeb 29, 2024ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3860590

ARENA PHARMACEUTICALS
Application Number
EP19790404A
Filing Date
Oct 3, 2019
Status
Revoked
Jan 3, 2025
Publication Date
Jun 7, 2023